A9576 HCPCS code: Injection, gadoteridol, (prohance multipack), per ml
A9576 is the HCPCS Level II code for injection, gadoteridol, (prohance multipack), per ml. In 2024 Medicare paid an average of $1.14 per service for A9576 across 279,998 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 100 per day on outpatient hospital claims. Medicare volume fell 2% from 2022 to 2024 (286,282 to 279,998 services). In 2024, about 860 clinicians billed Medicare for A9576 for 17,612 beneficiaries; New York, Virginia, Florida accounted for 48% of services.
Code details
| Field | Value |
|---|---|
| Section | A codes — Transportation, medical/surgical supplies and miscellaneous |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | I1E |
| Added | 2008-01-01 |
| Last action effective | 2008-01-01 |
Who bills A9576 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 860 |
| Medicare beneficiaries | 17,612 |
| States with claims | 35 |
| Share of services in top 3 states (New York, Virginia, Florida) | 48% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for A9576, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 286,282 | 18,511 | $1.42 | $1.11 |
| 2023 | 312,318 | 19,960 | $1.40 | $1.10 |
| 2024 | 279,998 | 17,612 | $1.46 | $1.14 |
States with the most A9576 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| New York | 51,435 | $1.16 |
| Virginia | 46,842 | $1.09 |
| Florida | 35,194 | $1.17 |
| Colorado | 30,627 | $1.16 |
| California | 17,284 | $1.13 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 100 | Prescribing Information |
| practitioner claims | 100 | Prescribing Information |
What changed for A9576
- 2008-01-01: A9576 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code A9576?
A9576 is the HCPCS Level II code for injection, gadoteridol, (prohance multipack), per ml. Short descriptor: "Inj prohance multipack".
How much does Medicare pay for A9576?
In 2024, the average Medicare payment was $1.14 per service (average allowed $1.46).
Does Medicare cover A9576?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of A9576 can be billed per day?
100 on outpatient hospital claims; 100 on practitioner claims (NCCI medically unlikely edits).
Related A95 codes
- A9500 — Technetium tc-99m sestamibi, diagnostic, per study dose
- A9501 — Technetium tc-99m teboroxime, diagnostic, per study dose
- A9502 — Technetium tc-99m tetrofosmin, diagnostic, per study dose
- A9503 — Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries
- A9504 — Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries
- A9505 — Thallium tl-201 thallous chloride, diagnostic, per millicurie
- A9506 — Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible
- A9507 — Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries
- A9508 — Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie
- A9509 — Iodine i-123 sodium iodide, diagnostic, per millicurie
- A9510 — Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries
- A9512 — Technetium tc-99m pertechnetate, diagnostic, per millicurie
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under A9576
- Watch A9576 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for A9576
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.